1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-Q

 [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
       EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 1997

                                       OR

 [   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934


                         Commission file number 0-15701


                    NATURAL ALTERNATIVES INTERNATIONAL, INC.
             (Exact name of registrant as specified in its charter)


Delaware                                                  84-1007839
(State of other jurisdiction of incorporation or         (I.R.S. Employer
organization)                                            Identification No.)

              1185 LINDA VISTA DRIVE, SAN MARCOS, CALIFORNIA 92069
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (760) 744-7340
              (Registrant's telephone number, including area code)


Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.



Yes [X]  No [ ]





                                    5,429,764

     (Number of shares of common stock of the registrant outstanding as of
                                April 30, 1997)




                                        1

   2

                    NATURAL ALTERNATIVES INTERNATIONAL, INC.
                         PART I - FINANCIAL INFORMATION

                           CONSOLIDATED BALANCE SHEETS

                                     ASSETS

March 31 1997 June 30 (Unaudited) 1996 ----------- ----------- CURRENT ASSETS: Cash and cash equivalents $ 3,280,994 $ 1,887,427 Accounts receivable - less allowance for doubtful accounts of $436,000 at March 31, 1997 and $319,000 at June 30, 1996 4,237,826 5,026,204 Accounts receivable - affiliated company 580,490 932,490 Inventory 8,963,616 6,399,592 Notes receivable - current portion 126,213 157,155 Deferred income taxes 520,000 425,000 Deposits 252,854 100,513 Other current assets 827,283 781,754 ----------- ----------- TOTAL CURRENT ASSETS 18,789,276 15,710,135 ----------- ----------- PROPERTY AND EQUIPMENT, at cost, less accumulated depreciation and amortization of $5,547,040 at March 31, 1997 and $4,641,640 at June 30, 1996 7,940,856 7,278,078 ----------- ----------- OTHER ASSETS: Receivable from affiliated company 200,000 -0- Other investments 68,737 74,890 Notes receivable, less current portion 277,062 285,470 Other non-current assets 357,058 212,618 ----------- ----------- TOTAL OTHER ASSETS 902,857 572,978 ----------- ----------- TOTAL ASSETS $27,632,989 $23,561,191 =========== ===========
(continued) 2 3 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION CONSOLIDATED BALANCE SHEETS (continued) LIABILITIES AND STOCKHOLDERS' EQUITY
March 31 1997 June 30 (Unaudited) 1996 ------------ ------------ CURRENT LIABILITIES: Accounts payable $ 5,330,429 $ 3,658,897 Current installments of long-term debt 210,533 234,736 Current installments of capital lease obligations 24,392 22,860 Accrued compensation and employee benefits 246,465 280,340 Line of credit 350,000 -0- Income taxes payable 139,599 520,246 Customer deposits 2,606 2,606 ----------- ----------- TOTAL CURRENT LIABILITIES 6,304,024 4,719,685 Deferred income taxes 357,000 357,000 Long-term debt, less current installments 1,139,633 1,276,118 Capital lease obligations, less current installments 29,422 48,802 ----------- ----------- TOTAL LIABILITIES 7,830,079 6,401,605 ----------- ----------- STOCKHOLDERS' EQUITY: Preferred stock; $.01 par value; 500,000 shares authorized; none issued or outstanding -- -- Common stock; $.01 par value; 8,000,000 shares authorized; issued and outstanding 5,408,875 at March 31, 1997 and 5,351,875 at June 30, 1996 54,089 53,519 Additional paid-in capital 6,578,801 6,220,196 Retained earnings 13,211,395 10,901,093 Net unrealized losses on investments (41,375) (15,222) ----------- ----------- TOTAL STOCKHOLDERS' EQUITY 19,802,910 17,159,586 ----------- ----------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $27,632,989 $23,561,191 =========== ===========
See accompanying notes to consolidated financial statements 3 4 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
For the Three Months Ended March 31 1997 1996 ----------- ----------- Net sales $11,406,325 $12,782,137 Cost of goods sold 8,540,258 9,329,320 ----------- ----------- GROSS PROFIT 2,866,067 3,452,817 Selling, general & administrative expenses 1,937,328 1,763,861 ----------- ----------- OPERATING INCOME 928,739 1,688,956 ----------- ----------- Other income (expense): Interest income 42,788 21,090 Interest expense (34,890) (48,861) Other, net -- 17,217 ----------- ----------- 7,898 (10,554) ----------- ----------- EARNINGS BEFORE INCOME TAXES 936,637 1,678,402 Income taxes 376,000 673,000 ----------- ----------- NET EARNINGS $ 560,637 $ 1,005,402 =========== =========== NET EARNINGS PER COMMON SHARE: Primary and fully diluted $ .10 $ .18 ============ ============
See accompanying notes to consolidated financial statements 4 5 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the Nine Months Ended March 31 ----------------------------- (Unaudited) 1997 1996 ----------- ----------- Net sales $35,473,581 $34,889,892 Cost of goods sold 26,130,920 25,842,322 ----------- ----------- GROSS PROFIT 9,342,661 9,047,570 Selling, general & administrative expenses 5,508,856 5,166,568 ----------- ----------- OPERATING INCOME 3,833,805 3,881,002 ----------- ----------- Other income (expense): Interest income 127,334 68,771 Interest expense (111,992) (116,514) Other, net (8,845) 32,429 ----------- ----------- 6,497 (15,314) ----------- ----------- EARNINGS BEFORE INCOME TAXES 3,840,302 3,865,688 Income taxes 1,530,000 1,536,000 ----------- ----------- NET EARNINGS $ 2,310,302 $ 2,329,688 =========== =========== NET EARNINGS PER COMMON SHARE: Primary and fully diluted $ .41 $ .42 =========== =========== See accompanying notes to consolidated financial statements 5 6 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)
Net Common Stock Additional Unrealized ---------------------------- Paid-In Retained Gains Shares Amount Capital Earnings (Losses) Total ----------- ----------- ------------ ------------ ------------ ------------ Balance at June 30, 1996 5,351,875 $53,519 $6,220,196 $10,901,093 $(15,222) $17,159,586 Issuance of common stock upon exercise of employee stock options 57,000 570 273,005 -- -- 273,575 Income tax benefit from stock options -- -- 85,600 -- -- 85,600 exercised Net unrealized gains (losses) on -- -- -- -- (26,153) (26,153) investments -- -- -- 2,310,302 -- 2,310,302 ---------- -------- ---------- ----------- --------- ----------- Net earnings Balance at 5,408,875 $54,089 $6,578,801 $13,211,395 $(41,375) $19,802,910 ========== ======== ========== =========== ======== =========== March 31, 1997
See accompanying notes to consolidated financial statements 6 7 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
For the Nine Months Ended March 31 1997 1996 ----------- ----------- CASH FLOWS FROM OPERATING ACTIVITIES: Net earnings $ 2,310,302 $ 2,329,688 Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: Bad debt expense 141,621 292,203 Tax benefit on option exercise 85,600 92,000 Depreciation and amortization 942,429 775,783 Deferred income taxes (95,000) 140,000 (Gain) loss on disposal of assets (9,099) 11,038 (Gain) loss on disposal of investments (19,713) (39,120) Changes in operating assets and liabilities: (Increase) decrease in: Accounts receivable 1,038,821 31,185 Inventory (2,564,024) (2,912,831) Deposits (152,341) 25,086 Other assets (159,838) 109,628 (Decrease) increase in: Accounts payable 1,671,532 (126,388) Accrued compensation and employee benefits (33,875) (360,043) Income taxes payable (380,647) (211,054) Other current liabilities -0- 19,484 ----------- ----------- 2,775,768 176,659 ----------- ----------- NET CASH PROVIDED BY OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES: Proceeds from sale of property and equipment -0- 55,337 Proceeds from sale of investments -0- 50,120 Receivable from affiliated company (200,000) -- Capital expenditures (1,586,063) (1,129,852) ---------- ---------- Other investments (20,000) (35,582) Issuance of notes receivable (82,409) (65,489) Repayment of notes receivable 88,948 94,580 Other (27,716) -- ----------- ----------- NET CASH (USED IN) INVESTING ACTIVITIES (1,827,240) (1,030,886) ----------- -----------
(continued) 7 8 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION CONSOLIDATED STATEMENTS OF CASH FLOWS (continued) (Unaudited)
For the Nine Months Ended March 31 -------------------------- 1997 1996 ----------- ----------- CASH FLOWS FROM FINANCING ACTIVITIES: Payments on long-term debt and capital leases $ (178,536) $ (176,455) Proceeds from issuance of common stock 273,575 197,397 Borrowings on line of credit, net 350,000 -- ---------- ---------- Net Cash Provided by Financing Activities 445,039 20,942 ---------- ---------- Net Increase (Decrease) in Cash and Cash Equivalents 1,393,567 (833,285) Cash and Cash Equivalents at Beginning of Period 1,887,427 2,526,839 ---------- ---------- Cash and Cash Equivalents at End of Period $3,280,994 $1,693,554 ========== ==========
See accompanying notes to consolidated financial statements 8 9 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 1 - BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting of a normal recurring nature considered necessary for a fair presentation, have been included. It is suggested that these consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended June 30, 1996. The results of operations for the periods ended March 31, 1997 and 1996 are not necessarily indicative of the operating results for the full year. Certain amounts in prior period financial statements have been reclassified to conform to the current period financial statements. NOTE 2 - PRINCIPLES OF CONSOLIDATION The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Millennium Health International, Inc. (formerly Pro-Lean, Inc. and prior to that Sonergy, Inc.), CellLife International, Inc. and CellLife Pharmaceuticals International, Inc. All significant intercompany accounts and transactions have been eliminated. NOTE 3 - INVENTORIES Inventories are comprised of:
March 31 June 30 1997 1996 ---------- ---------- Raw materials $4,493,131 $2,865,438 Work in process 4,133,841 2,911,778 Finished goods 336,644 622,376 ---------- ---------- $8,963,616 $6,399,592 ========== ==========
9 10 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 4 - NET EARNINGS PER SHARE Primary earnings per share is computed based upon the weighted average number of shares outstanding during the period plus the dilutive effects of common shares contingently issuable from stock options. Fully diluted earnings per share reflect additional dilution related to common stock equivalents due to the use of the market price at the end of the period, when higher than the average price for the period. Common stock options and common stock purchase warrants are excluded from the computation of net earnings per share if their effect is anti-dilutive. The weighted average number of shares outstanding and common stock equivalents are as follows:
For the Three Months For the Nine Months Ended March 31 Ended March 31 -------------- -------------- 1997 1996 1997 1996 --------- --------- --------- --------- Primary and fully diluted 5,666,313 5,607,120 5,644,542 5,586,692
NOTE 5 - STOCKHOLDERS' EQUITY Effective June 5, 1992, the Company adopted the 1992 Incentive Stock Option Plan (Plan) and reserved a total of 200,000 common shares for issuance to key employees of the Company. The Plan provides that no option may be granted at an exercise price less than the fair market value of the common share of the Company on the date of grant. On September 9, 1993, 200,000 shares were granted at the fair market value price of $4.875 per share. Effective December 9, 1994, the Shareholders approved an amendment to the Plan, increasing the number of common shares that may be granted thereunder from 200,000 to 500,000, to enable additional officers, directors, and employees to participate in the Plan. Also effective June 5, 1992, the Company adopted the 1992 Nonqualified Stock Option Plan and reserved a total of 250,000 common shares for issuance to officers, employees, and consultants of the Company. On September 9, 1993, 250,000 options were granted at the fair market value price of $4.875 per share. Effective December 9, 1994, the Board of Directors approved the 1994 Nonqualified Stock Option Plan and reserved a total of 500,000 common shares for issuance to officers, employees, and consultants of the Company. On January 24, 1995, 500,000 options were granted at the fair market value price of $4.625 per share. (continued) 10 11 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 5 - STOCKHOLDERS' EQUITY (continued) Effective January 24, 1995, 100,000 options were granted pursuant to a consulting agreement at the fair market value price of $4.625 per share. On September 20, 1996, 45,000 options were granted pursuant to a consulting agreement at prices ranging from $9.00 to $15.00 per share. None of these options had been exercised as of March 31, 1997. Information regarding the Company's stock option plans is summarized below:
1992 1992 1994 Incentive Nonqualified Nonqualified Plan Plan Plan ------- ------- ------- Outstanding at June 30, 1996 124,002 233,498 489,000 For the six months ended December 31, 1996- 22,222 4,778 13,000 Exercised For the three months ended March 31, 1997- 4,722 2,778 4,500 ------- ------- ------- Exercised 97,058 225,942 471,500 ======= ======= ======= Outstanding at March 31, 1997 97,058 225,942 471,500 ======= ======= ======= Exercisable at March 31, 1997 300,000 -0- -0- Available for grant at March 31, 1997 ======= ======= =======
NOTE 6 - PENSION PLAN Effective January 1, 1997, the Company adopted a defined benefit pension plan (the "Plan") covering substantially all of its employees. The benefits are based on years of service and the employee's compensation during the five years before retirement. The Company will make annual contributions to the Plan equal to the maximum amount that can be deducted for income tax purposes. For the three months ended March 31, 1997, the estimated current service cost (normal cost) is $44,000 and the amortized portion of the unfunded estimated accrued liability for prior service cost, using a 30-year funding period, is $23,000. Such amounts have been accrued in the current period. 11 12 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NOTE 7 - MAJOR CUSTOMERS The Company had substantial sales to five separate customers during one or more of the periods shown in the following table. The loss of any of these customers could have an adverse impact on the Company's revenues and earnings in the short-term. Sales to these customers, by industry segment, were as follows:
Three Months Ended Nine Months Ended --------------------------------------- ------------------------------------- March 31, 1997 March 31, 1996 March 31, 1997 March 31, 1996 ----------- ---- ----------- ---- ----------- --- ----------- ---- Industry Sales by Sales by Sales by Sales by Segment Customer %(1) Customer %(1) Customer %(1) Customer %(1) - ----------- ----------- ---- ----------- ---- ----------- --- ----------- ---- Multi-level Distribution: Customer 1 $ 5,527,135 49% $ 3,686,737 29% $12,873,152 36% $10,891,634 31% Customer 2 1,280,611 11% 4,421,224 35% 6,158,760 18% 10,125,883 29% Customer 3 1,708,915 15% NA NA NA NA NA Customer 4 NA NA NA NA 3,581,245 10% NA NA ----------- ---- ----------- ---- ----------- --- ----------- ---- $ 8,516,661 75% $ 8,107,961 64% $22,613,157 64% $21,017,517 60% =========== ==== =========== ==== =========== === =========== ==== Weight Loss: Customer 5 NA NA $ 1,744,896 14% NA NA NA NA =========== ==== =========== ==== =========== === =========== ====
(1) Percent of total sales. 12 13 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS RESULTS OF OPERATIONS THIRD QUARTER OF FISCAL 1997 AND 1996 The Company's consolidated net sales for the quarter ending March 31, 1997, amounted to $11.4 million, a decrease of $1.4 million from the $12.8 million generated during the quarter ending March 31, 1996. The 11% decrease in revenue is primarily attributable to a build-up of inventory by a major client in the prior quarter followed by a decline in the same client's demand for products purchased from the Company in the current quarter. International sales for the quarter ending March 31, 1997, amounted to $.5 million compared to $.8 million for the quarter ending March 31, 1996. The decrease is the result of a major client restructuring its European operations coupled with a declining demand for the same client's products in Europe. Gross profit margins were 25.1% for the quarter ending March 31, 1997, compared to 27.0% for the quarter ending March 31, 1996. The marginal decrease in margins was due to product mix skewed more to price sensitive bulk sales. Selling, general and administrative expenses increased as a percentage of revenues to 17.0% for the quarter ending March 31, 1997 from 13.8% for the quarter ending March 31, 1996. The increase ($173,000 in real dollars) was primarily due to expenses associated with conducting new clinical studies combined with the establishment of a new tablet manufacturing facility. Net earnings for the quarter ending March 31, 1997, amounted to $.6 million, a $.4 million decrease from the $1.0 million in net income produced for the quarter ending March 31, 1996. The decrease in net earnings was due primarily to a decline in sales, reduced margins and expenses associated with the installation of a new tablet manufacturing facility. Earnings per share for the quarter ending March 31, 1997, was $.10 compared to $.18 for the quarter ending March 31, 1996. The decrease was due to the reasons discussed above and was only slightly impacted by the increase in the Company's weighted average number of shares outstanding and the dilutive effect of common stock equivalents. NINE MONTHS ENDING MARCH 31, 1997 AND 1996 The Company's consolidated net sales for the nine months ending March 31, 1997, amounted to $35.5 million, an increase of $.6 million from the $34.9 million generated during the nine months ending March 31, 1996. The increase was due, primarily, to increased sales to existing customers. International sales for the nine months ending March 31, 1997, amounted to $1.3 million compared to $2.6 million for the nine months ending March 31, 1996. The decrease is the result of a major client restructuring its European operations coupled with a declining demand for the same client's products in Europe. 13 14 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART I - FINANCIAL INFORMATION MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS NINE MONTHS ENDING MARCH 31, 1997 AND 1996 (Continued) Gross profit margins were 26.3% for the nine months ending March 31, 1997, compared to 25.9% for the nine months ending March 31, 1996. The increase in margins was due to a change in sales mix for the current period. Gross profits increased by $295,000, or 3.3% as a result of the 1.7% increase in sales and the increase in gross margins. Selling, general and administrative expenses increased moderately as a percentage of revenues to 15.5% for the nine months ending March 31, 1997 from 14.8% for the nine months ending March 31, 1996. Selling, general and administrative expenses for the nine months ending March 31, 1997 increased $342,000 or 6.6% over the nine months ending March 31, 1996. Net earnings for the nine months ending March 31, 1997 and 1996, amounted to $2.3 million. The increase in gross profit was offset by the increase in selling, general and administrative expenses. Earnings per share for the nine months ending March 31, 1997, was $.41 compared to $.42 for the nine months ending March 31, 1996. The decrease was due to the reasons discussed above and the slight impact from the increase in the Company's weighted average number of shares outstanding and the dilutive effect of common stock equivalents. LIQUIDITY AND CAPITAL RESOURCES At March 31, 1997, the Company had working capital of $12,485,000 compared to $10,990,000 as of June 30, 1996. The working capital items which represented the most significant changes were inventory, which increased by $2.6 million and accounts payable, which increased by $1.7 million. Inventory levels at March 31, 1997, compared to sales, increased moderately relative to historical levels, due principally to forward purchase buys of raw materials. The Company has purchase commitments approximating $300,000 for additional production equipment which is expected to be placed in service in the fourth quarter. The Company will also be expending approximately $400,000 in the fourth quarter, primarily for leasehold improvements. These expenditures are expected to be funded from a combination of cash flow from operating activities and draws on the Company's lines of credit. The Company believes it has sufficient sources of funds to finance its ongoing operations and meet its capital asset purchases, as well as future growth through a combination of internally generated cash flow, revolving lines of credit and equipment financing. The Company has revolving line of credit agreements permitting borrowings up to $3,000,000, which are secured by the Company's receivables, inventory, equipment, and vehicles and bear interest at the bank's prime rate. The bank's prime rate at March 31, 1997 was 8.5%. The lines of credit expire on December 5, 1997; however, management expects such lines to be renewed in the normal course of business. The company had borrowings of $350,000 as of March 31, 1997, and no borrowings at June 30, 1996, under these credit lines. 14 15 NATURAL ALTERNATIVES INTERNATIONAL, INC. PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS The Company is involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, based in part on the advice of counsel, the ultimate disposition of these matters will not have a material adverse impact on the Company's consolidated financial position, operations or cash flows. ITEM 2. CHANGES IN SECURITIES None. ITEM 3. DEFAULTS BY THE COMPANY ON ITS SENIOR SECURITIES None. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None. ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (a) Exhibits: The following exhibits are filed herewith: 11.0. Computation of weighted average number common shares outstanding. 27.0. Financial Data Schedule (b) No reports on Form 8-K were filed during the quarter ended March 31, 1997. 15 16 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NATURAL ALTERNATIVES INTERNATIONAL, INC. MARK A. LE DOUX Date: May 14, 1997 - -------------------- Mark A. Le Doux Chief Executive Officer WILLIAM P. SPENCER Date: May 14, 1997 - -------------------- William P. Spencer President 16
   1



                                                                      EXHIBIT 11

                    NATURAL ALTERNATIVES INTERNATIONAL, INC.

                 STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
                                   (unaudited)

                    For the Three Months Ended March 31, 1997

Primary and Fully Diluted Days Weighted Outstanding Out- Average ------------------ stand- Shares From To ing Shares Outstanding ---- -- --- ------ ----------- Beginning shares 1/01/97 3/31/97 90 5,391,875 5,391,875 --------- --------- Dilutive effect of common stock equivalents: 889,500 stock options at average price per share 267,388 Exercise of employee stock options: 01/06/97 3/31/97 84 2,500 2,333 02/07/97 3/31/97 52 2,000 1,156 2/20/97 3/31/97 39 5,000 2,167 03/06/97 3/31/97 25 3,000 833 03/14/97 3/31/97 17 1,000 189 03/18/97 3/31/97 13 1,500 216 03/24/97 3/31/97 7 2,000 156 --------- --------- Ending shares 5,408,875 5,666,313 Net Earnings $ 560,637 ========= Net Earnings Per Share $ .10 =========
(Continued) 17 2 EXHIBIT 11 NATURAL ALTERNATIVES INTERNATIONAL, INC. STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS (continued) (unaudited) For the Nine Months Ended March 31, 1997
Primary and Fully Diluted Days Weighted Outstanding Out- Average ----------- stand- Shares From To ing Shares Outstanding ---- -- --- ------ ----------- Beginning shares 07/01/96 3/31/97 274 5,351,875 5,351,875 Dilutive effect of common stock equivalents: 889,500 stock options at average price per share 259,318 Exercise of employee stock options: 07/05/96 3/31/97 269 5,000 4,909 07/22/96 3/31/97 252 4,000 3,679 07/25/96 3/31/97 249 6,000 5,453 08/07/96 3/31/97 236 4,000 3,446 08/13/96 3/31/97 230 5,000 4,197 10/21/96 3/31/97 162 15,000 8,814 11/04/96 3/31/97 147 1,000 536 01/06/97 3/31/97 84 2,500 766 02/07/97 3/31/97 52 2,000 380 02/20/97 3/31/97 39 5,000 712 03/06/97 3/31/97 25 3,000 274 03/14/97 3/31/97 17 1,000 62 03/18/97 3/31/97 13 1,500 70 03/24/97 3/31/97 7 2,000 51 ------ -------------- Ending shares 5,408,875 5,644,542 ========= ========= Net Earnings $ 2,310,302 =========== Net Earnings Per Share $ .41 ===========
(Continued) 18 3 EXHIBIT 11 NATURAL ALTERNATIVES INTERNATIONAL, INC. STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS (continued) (unaudited) For the Three Months Ended March 31, 1996
Primary and Fully Diluted Days Weighted Outstanding Out- Average ----------- stand- Shares From To ing Shares Outstanding ---- -- --- ------ ----------- Beginning shares 1/01/96 3/31/96 91 5,297,375 5,297,375 Dilutive effect of common stock equivalents: 1,000,000 stock options at average price per share 309,679 Exercise of employee stock options 3/25/96 3/31/96 6 1,000 66 ---------- ---------- Ending shares 5,297,375 5,607,120 ========== ========== Net Earnings $1,005,402 ========== Net Earnings Per Share $ .18 ==========
(Continued) 19 4 EXHIBIT 11 NATURAL ALTERNATIVES INTERNATIONAL, INC. STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS (continued) (unaudited) For the Nine Months Ended March 31, 1996
Primary and Fully Diluted Days Weighted Outstanding Out- Average ------------ stand- Shares From To ing Shares Outstanding ---- -- --- ------ ----------- Beginning shares 07/01/95 3/31/96 275 5,257,875 5,257,875 Dilutive effect of common stock equivalents: 1,000,000 stock options at average price per share 304,026 Exercise of employee stock options 08/21/95 3/31/96 223 1,500 1,216 Exercise of employee stock options 09/20/95 3/31/96 194 20,500 14,462 Exercise of employee stock options 11/09/95 3/31/96 143 15,000 7,800 Exercise of employee stock options 11/10/95 3/31/96 142 2,500 1,291 Exercise of employee stock options 3/25/96 3/31/96 6 1,000 22 ---------- ---------- Ending shares 5,298,375 5,586,692 ========== ========== Net Earnings $2,329,688 ========== Net Earnings Per Share $ .42 ==========
20
 

5 THE SCHEDULE CONTAINS SUMMARY FINANICIAL INFORMATION EXTRACTED FROM THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE NINE MONTHS ENDED MARCH 31, 1997, AND IS QUALIFIED IN ITS ETIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. 3-MOS JUN-30-1997 JUL-01-1996 MAR-31-1997 3,280,994 0 5,254,316 436,000 8,963,616 18,789,276 13,487,896 5,547,040 27,632,989 6,304,024 1,139,633 0 0 54,089 19,748,821 27,632,989 35,473,581 35,473,581 26,130,920 5,508,856 0 15,000 127,334 3,840,302 1,530,000 2,310,302 0 0 0 2,310,302 .41 .41